Rose Guahk is Chief Operating Officer at Genome Opinion and served since 2021. Her time has been spent strategically leading Genome Opinion as a worldwide pioneer in biomarker-driven precision medicine, shaping the company for long-term growth through multiple portfolio. She brings comprehensive leadership expertise resulting from decades of service as an executive in the pharmaceutical industry. Before joining Genome Opinion, she was a Country President for Novartis Oncology in Korea. During her tenure at Novartis, she was responsible for build-out the organization to help bringing innovative medicines to Korean patients.  Before that, she held several leadership roles at Merck, including responsibility for all business and commercial operations for diverse disease areas including Immunology, Vaccines, Women’ health, Diabetes, Musculoskeletal and Cardiovascular.

EDUCATION

  • MBA, Yonsei University, Korea
  • Bachelor of Pharmacy, School of pharmacy, Seoul National University, Korea

Rose Guahk, MBA / Pharmacist

Chief Operating Officer